Cost & Pricing Information | ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)

INDICATIONS

Close
  • ABRAXANE® is a prescription medicine used to treat advanced breast cancer in people who have already received certain other medicines for their cancer.
  • ABRAXANE® is a prescription medicine used to treat advanced non–small cell lung cancer, in combination with carboplatin, in people who cannot be treated with surgery or radiation.
  • ABRAXANE® is a prescription medicine used to treat advanced pancreatic cancer, when used in combination with gemcitabine, as the first medicine you receive for advanced pancreatic cancer.

Close

BACK

Pricing Information

Like many patients, knowing what you may pay for treatment can be a major concern. That’s why Bristol Myers Squibb (BMS) is committed to helping you understand your out-of-pocket (OOP) costs and possible resources that may help make them more affordable.

Click below to learn more about your medication cost based upon your infusion schedule and insurance coverage.

For people prescribed ABRAXANE for Advanced (Metastatic) Breast Cancer

  • The list price of ABRAXANE is $7,900.30 per infusion when given as 260 mg/m2 every 3 weeks.* Most patients will pay less.

*This price does not include the cost of administration and other medicines or infusion center costs. This list price is current as of January 2024.

  • If you have commercial insurance

    You could pay as little as $0 per infusion with the BMS Oncology Co-Pay Assistance Program. Learn about this program.

  • If you have Medicare

    You could pay $0–$1,866 per infusion if you are receiving ABRAXANE (depending on your specific Medicare benefits). The OOP cost for around 50% of infusions is $10 or less. If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your ABRAXANE costs. If you have Medicare Part C, there is an out-of-pocket maximum and what you will pay for ABRAXANE depends on your plan’s benefit design and the level of other healthcare expenses you have during the year. Please check with your Medicare plan administrator for further details.

  • If you have Medicaid

    You could pay $0–$20 per infusion (depending on state plan). To find out if you qualify for Medicaid, or to get more information about co-payments in your state, please use this link to visit the Medicaid website.

  • If you do not have insurance coverage

    If you do not have medical coverage or your insurance does not cover ABRAXANE, you can expect to pay the list price shown above. Patients without insurance are encouraged to call 1-800-861-0048 to explore potential options.

  • For additional information, the BMS Access Support® Program provides resources to help patients understand their insurance coverage and find information on sources of financial support.

    As part of the BMS Access Support program, the BMS Oncology Co-Pay Assistance Program may help eligible commercially insured patients pay $0 per medication. BMS will cover the rest of the cost, up to $10,000 per year per product.

    Please visit BMS Access Support or call BMS Access Support at 1-800-861-0048, 8 AM to 8 PM ET, Monday to Friday.

For people prescribed ABRAXANE for Advanced Non-Small Cell Lung Cancer

The list price of ABRAXANE is $3,160.12 per infusion when given as 100 mg/m2 on days 1, 8, and 15 of each 21-day cycle.* Most patients will pay less.

*This price does not include the cost of administration and other medicines or infusion center costs. This list price is current as of January 2024.

  • If you have commercial insurance

    You could pay as little as $0 per infusion with the BMS Oncology Co-Pay Assistance Program. Learn about this program.

  • If you have Medicare

    You could pay $0–$1,417 per infusion if you are receiving ABRAXANE (depending on your specific Medicare benefits). The OOP cost for around 50% of infusions is $10 or less. If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your ABRAXANE costs. If you have Medicare Part C, there is an out-of-pocket maximum and what you will pay for ABRAXANE depends on your plan’s benefit design and the level of other healthcare expenses you have during the year. Please check with your Medicare plan administrator for further details.

  • If you have Medicaid

    You could pay $0–$20 per infusion (depending on state plan). To find out if you qualify for Medicaid, or to get more information about co-payments in your state, please use this link to visit the Medicaid website.

  • If you do not have insurance coverage

    If you do not have medical coverage or your insurance does not cover ABRAXANE, you can expect to pay the list price shown above. Patients without insurance are encouraged to call 1-800-861-0048 to explore potential options.

  • For additional information, the BMS Access Support® Program provides resources to help patients understand their insurance coverage and find information on sources of financial support.

    As part of the BMS Access Support program, the BMS Oncology Co-Pay Assistance Program may help eligible commercially insured patients pay $0 per medication. BMS will cover the rest of the cost, up to $10,000 per year per product.

    Please visit BMS Access Support or call BMS Access Support at 1-800-861-0048, 8 AM to 8 PM ET, Monday to Friday.

For people prescribed ABRAXANE for Advanced (Metastatic) Pancreatic Cancer

The list price of ABRAXANE is $4,740.18 per infusion when given as 125 mg/m2 on days 1, 8, and 15 of each 28-day cycle.* Most patients will pay less.

*This price does not include the cost of administration and other medicines or infusion center costs. This list price is current as of January 2024.

  • If you have commercial insurance

    You could pay as little as $0 per infusion with the BMS Oncology Co-Pay Assistance Program. Learn about this program.

  • If you have Medicare

    You could pay $0–$2,107 per infusion if you are receiving ABRAXANE (depending on your specific Medicare benefits). The OOP cost for around 50% of infusions is $10 or less. If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your ABRAXANE costs. If you have Medicare Part C, there is an out-of-pocket maximum and what you will pay for ABRAXANE depends on your plan’s benefit design and the level of other healthcare expenses you have during the year. Please check with your Medicare plan administrator for further details.

  • If you have Medicaid

    You could pay $0–$20 per infusion (depending on state plan). To find out if you qualify for Medicaid, or to get more information about co-payments in your state, please use this link to visit the Medicaid website.

  • If you do not have insurance coverage

    If you do not have medical coverage or your insurance does not cover ABRAXANE, you can expect to pay the list price shown above. Patients without insurance are encouraged to call 1-800-861-0048 to explore potential options.

  • For additional information, the BMS Access Support® Program provides resources to help patients understand their insurance coverage and find information on sources of financial support.

    As part of the BMS Access Support program, the BMS Oncology Co-Pay Assistance Program may help eligible commercially insured patients pay $0 per medication. BMS will cover the rest of the cost, up to $10,000 per year per product.

    Please visit BMS Access Support or call BMS Access Support at 1-800-861-0048, 8 AM to 8 PM ET, Monday to Friday.

BACK

MORE

Important Safety Information

WARNING – DECREASED BONE MARROW ACTIVITY

  • Do not take ABRAXANE if your white blood cell count is below 1500 cells/mm3 (neutropenia), since you may be more likely to get a serious infection. While taking ABRAXANE, you must get regular blood tests to check for any problems that could develop
  • ABRAXANE contains albumin, a substance found in human blood. Do not substitute for or with other paclitaxel formulations

WHO SHOULD NOT RECEIVE ABRAXANE?

  • Do not receive ABRAXANE if:
  • your white blood cell count is below 1500 cells/mm3
  • you have had a severe allergic reaction to ABRAXANE

SERIOUS SIDE EFFECTS

ABRAXANE may cause serious side effects, including:

  • Severe decreased blood cell counts. ABRAXANE can cause a severe decrease in neutrophils, a type of white blood cell which helps fight infections, and blood cells called platelets which help to clot blood. Your healthcare provider will check your blood cell count during your treatment with ABRAXANE
  • Severe nerve problems (neuropathy). Tell your healthcare provider if you have numbness, tingling, pain, or weakness in your hands or feet
  • Severe infection (sepsis). If you receive ABRAXANE in combination with gemcitabine, infections can be severe and lead to death. Tell your healthcare provider right away if you have a fever (temperature greater than 100.4° F) or develop signs of infection
  • Lung or breathing problems. If you receive ABRAXANE in combination with gemcitabine, lung or breathing problems may be severe and can lead to death. Tell your healthcare provider right away if you suddenly get a dry cough that will not go away or shortness of breath
  • Severe allergic reactions. Severe allergic reactions are medical emergencies that can happen in people who receive ABRAXANE and can lead to death. You may have an increased risk of having an allergic reaction to ABRAXANE if you are allergic to other taxane medicines. Your healthcare provider will monitor you closely for allergic reactions during your infusion of ABRAXANE. Tell your healthcare provider right away if you get any of these signs of a serious allergic reaction: trouble breathing, sudden swelling of your face, lips, tongue, throat, or trouble swallowing, hives (raised bumps), rash, or redness all over your body

OTHER RISKS

  • Treatment with ABRAXANE can make liver problems worse. If you have liver problems, your starting dose of ABRAXANE should be lowered or withheld
  • ABRAXANE contains albumin (human), a product of human blood
  • Do not breastfeed during your treatment and for two weeks after the last dose of ABRAXANE

RISKS TO PREGNANCY

  • If you are pregnant or become pregnant, ABRAXANE can harm your unborn baby. Your healthcare provider will check to see if you are pregnant before you start treatment with ABRAXANE. Women should not become pregnant and should use effective birth control (contraception) during treatment and for at least six months after the last dose of ABRAXANE. Talk to your doctor about birth control methods you can use during this time
  • ABRAXANE can harm the unborn baby of your partner
  • If you are a man, you should not father a child and should use effective birth control (contraception) during treatment and for at least three months after the last dose of ABRAXANE
  • ABRAXANE may cause fertility problems in males and females, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you

OTHER POSSIBLE SIDE EFFECTS

The most common side effects of ABRAXANE in people with breast cancer include:

  • hair loss
  • numbness, tingling, pain, or weakness in the hands or feet
  • tiredness
  • changes in your liver function tests
  • nausea
  • diarrhea
  • infections
  • decreased white blood cell count
  • abnormal heartbeat
  • joint and muscle pain
  • low red blood cell count (anemia). Red blood cells carry oxygen to your body tissues. Tell your healthcare provider if you feel weak, tired, or short of breath

The most common side effects of ABRAXANE in people with non-small cell lung cancer include:

  • low red blood cell count (anemia)
  • decreased platelet cell count
  • numbness, tingling, pain, or weakness in the hands or feet
  • tiredness
  • decreased white blood cell count
  • hair loss
  • nausea

The most common side effects of ABRAXANE in people with pancreatic cancer include:

  • decreased white blood cell count
  • numbness, tingling, pain, or weakness in the hands or feet
  • hair loss
  • diarrhea
  • vomiting
  • rash
  • tiredness
  • nausea
  • swelling in the hands or feet
  • fever
  • decreased appetite
  • signs of dehydration including, thirst, dry mouth, dark yellow urine, decreased urine, headache, or muscle cramps
  • Other side effects include vision problems, decreased appetite, kidney problems, constipation, and difficulty breathing
  • In some patients receiving ABRAXANE, severe heart and blood vessel side effects have occurred. These included chest pain, heart attack, fluid under the skin, blood clots in the veins or lungs, high blood pressure, stroke, and heart failure

OTHER IMPORTANT SAFETY INFORMATION ABOUT ABRAXANE

  • You should contact your doctor if you have signs or symptoms of vomiting, diarrhea, dehydration, cough, or breathing difficulties that do not go away, or signs of an allergic reaction. Tell your doctor if you have any other medical conditions
  • Treatment with ABRAXANE can cause irritation where the medicine is injected (injection site reactions). You should be monitored by your doctor or nurse during and after you receive ABRAXANE to make sure no problems occur at the injection site. In some cases, these problems occurred 7 to 10 days after the medicine was injected
  • It is not known whether ABRAXANE interacts with other drugs, so be sure to tell your doctor about any medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements you are taking
  • The safety and effectiveness in children have not been shown
  • ABRAXANE has not been adequately studied in people with severe kidney problems

These are not all the possible side effects of ABRAXANE. For more information, ask your doctor or pharmacist. You may report side effects to FDA at 1-800-FDA-1088.

INDICATIONS

ABRAXANE® is a prescription medicine used to treat advanced breast cancer in people who have already received certain other medicines for their cancer.

ABRAXANE® is a prescription medicine used to treat advanced non–small cell lung cancer, in combination with carboplatin, in people who cannot be treated with surgery or radiation.

ABRAXANE® is a prescription medicine used to treat advanced pancreatic cancer, when used in combination with gemcitabine, as the first medicine you receive for advanced pancreatic cancer.

Please see full Patient Information and Prescribing Information, including Boxed WARNING.

ABRAXANE® is a registered trademark of Abraxis BioScience, LLC. Abraxis BioScience, LLC is a wholly owned subsidiary of Bristol-Myers Squibb Company.
Access Support® is a registered trademark of Bristol-Myers Squibb Company. All Rights Reserved.

© 2021 Bristol-Myers Squibb Company.

2013-US-2100018 05/21

Privacy Policy  |  Legal Notice |
Your Privacy Choices